Gallay et al., 1995 - Google Patents
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integraseGallay et al., 1995
View PDF- Document ID
- 2545270604192833127
- Author
- Gallay P
- Swingler S
- Song J
- Bushman F
- Trono D
- Publication year
- Publication venue
- Cell
External Links
Snippet
The karyophilic properties of the viral matrix (MA) protein govern HIV nuclear import in nondividing cells such as macrophages. A critical regulator of this process is the C-terminal tyrosine phosphorylation of MA during virus maturation. Here, we reveal the mechanism of …
- 239000011159 matrix material 0 title abstract description 143
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—AIDS or HTLV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gallay et al. | HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase | |
Gallay et al. | HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator | |
US9896509B2 (en) | Use of antagonists of the interaction between HIV GP120 and α4β7 integrin | |
JP4234999B2 (en) | Multimer formation of HIV-1 VIF protein as a therapeutic target | |
Liu et al. | Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions | |
Gallay et al. | Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import | |
US5350835A (en) | Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids | |
Yung et al. | Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance | |
Swingler et al. | The Nef protein of human immunodeficiency virus type 1 enhances serine phosphorylation of the viral matrix | |
Harris | From negative factor to a critical role in virus pathogenesis: the changing fortunes of Nef | |
Stevenson | Portals of entry: uncovering HIV nuclear transport pathways | |
AU2002307229A1 (en) | Multimerization of HIV-1 Vif protein as a therapeutic target | |
US5773225A (en) | Screening method for the identification of compounds capable of abrogation HIV-1 gag-cyclophilin complex formation | |
Luo et al. | Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus | |
AU690694B2 (en) | Methods for the identification of compounds capable of abrogating HIV-1 VPR-RIP-1 binding interactions | |
US5639598A (en) | Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions | |
Ackerson et al. | Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A | |
Camaur et al. | Human immunodeficiency virus matrix tyrosine phosphorylation: characterization of the kinase and its substrate requirements | |
Dietrich et al. | Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein | |
JPH08510063A (en) | HIV immunoassay using recombinant protein and synthetic peptide reagents | |
JPH10502165A (en) | Detection of different HIV genotypes using synthetic peptides-improved immunoassay | |
CN114316062B (en) | Multispecific antibody targeting HIV gp120 protein and human CD3 molecule and application thereof | |
Singhal et al. | Nuclear export of simian immunodeficiency virus Vpx protein | |
KR0168447B1 (en) | T-lymphotropic retrovirus monoclonal antibodies | |
EP1800126B1 (en) | Compositions and methods for the detection of hiv-1/hiv-2 infection |